359 related articles for article (PubMed ID: 16966735)
1. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.
Bradford WD; Kleit AN; Nietert PJ; Steyer T; McIlwain T; Ornstein S
Health Aff (Millwood); 2006; 25(5):1371-7. PubMed ID: 16966735
[TBL] [Abstract][Full Text] [Related]
2. Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.
Hsiao FY; Tsai YW; Huang WF
Clin Ther; 2009 Nov; 31(11):2618-27. PubMed ID: 20110006
[TBL] [Abstract][Full Text] [Related]
3. Identifying early prescribers of cycloxygenase-2 inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing.
Groves KE; Schellinck T; Sketris I; MacKinnon NJ
Res Social Adm Pharm; 2010 Sep; 6(3):257-67. PubMed ID: 20813338
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: what is the potential impact of the withdrawal of rofecoxib?
Rahme E; Hunsche E; Toubouti Y; Chabot I
Arthritis Rheum; 2006 Feb; 55(1):27-34. PubMed ID: 16463408
[TBL] [Abstract][Full Text] [Related]
5. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
Bradford WD; Kleit AN; Nietert PJ; Ornstein S
Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
[TBL] [Abstract][Full Text] [Related]
6. The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.
Viale PH; Sanchez Yamamoto D
Oncol Nurs Forum; 2004 Jul; 31(4):777-83. PubMed ID: 15252431
[TBL] [Abstract][Full Text] [Related]
7. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.
Robinson AR; Hohmann KB; Rifkin JI; Topp D; Gilroy CM; Pickard JA; Anderson RJ
Arch Intern Med; 2004 Feb; 164(4):427-32. PubMed ID: 14980994
[TBL] [Abstract][Full Text] [Related]
8. Clinical inquiries. Do COX-2 inhibitors worsen renal function?
Wall R; Strickland C; Jamieson B; Lo V
J Fam Pract; 2007 Nov; 56(11):957-8. PubMed ID: 17976347
[No Abstract] [Full Text] [Related]
9. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing.
Spence MM; Teleki SS; Cheetham TC; Schweitzer SO; Millares M
Med Care Res Rev; 2005 Oct; 62(5):544-59. PubMed ID: 16177457
[TBL] [Abstract][Full Text] [Related]
10. Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.
Epstein RA
Yale J Health Policy Law Ethics; 2005; 5(2):741-70. PubMed ID: 16052898
[No Abstract] [Full Text] [Related]
11. Adoption of celecoxib and rofecoxib: a nationwide database study.
Helin-Salmivaara A; Huupponen R; Virtanen A; Klaukka T
J Clin Pharm Ther; 2005 Apr; 30(2):145-52. PubMed ID: 15811167
[TBL] [Abstract][Full Text] [Related]
12. Direct-to-consumer advertising affects provider / patient relationship.
Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
[TBL] [Abstract][Full Text] [Related]
13. Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly.
Graham SD; Hartzema AG; Sketris IS; Winterstein AG
Ann Pharmacother; 2008 Jun; 42(6):749-56. PubMed ID: 18430793
[TBL] [Abstract][Full Text] [Related]
14. Some current factors influencing the prescribing and use of psychiatric drugs.
Poulsen RL
Public Health Rep; 1992; 107(1):47-53. PubMed ID: 1738808
[TBL] [Abstract][Full Text] [Related]
15. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Velo GP; Sturkenboom M; Blin P; Moore N;
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):891-900. PubMed ID: 17351983
[TBL] [Abstract][Full Text] [Related]
16. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
Khanfar N; Loudon D; Sircar-Ramsewak F
Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
[TBL] [Abstract][Full Text] [Related]
17. The COX-2 inhibitors--an update.
Furberg CD
Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
[No Abstract] [Full Text] [Related]
18. Prescribing pattern of general practitioners for osteoarthritis in primary care settings in Bolu, Turkey.
Kartal M; Maral I; Coskun O
Saudi Med J; 2007 Dec; 28(12):1885-9. PubMed ID: 18060222
[TBL] [Abstract][Full Text] [Related]
19. A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders.
Klein D; MacDonald A; Drummond N; Cave A
Fam Pract; 2006 Dec; 23(6):659-65. PubMed ID: 17035286
[TBL] [Abstract][Full Text] [Related]
20. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population.
Rahme E; Choquette D; Beaulieu M; Bessette L; Joseph L; Toubouti Y; LeLorier J
Am J Med; 2005 Nov; 118(11):1262-70. PubMed ID: 16271911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
